Search Results 331-340 of 17039 for monoclonal antibody
Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
... antibody titer over the pre-vaccination levels, and to assess the ... Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways.
These proteins, called monoclonal antibodies, try to affect cells that are causing your problem. Having desensitization to aspirin. Aspirin is given in the ...
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
Three monoclonal antibody therapies — eculizumab, inebilizumab and satralizumab — have been approved for adults with NMOSD and AQP4-IgG autoantibodies.
Monoclonal antibodies, such as blinatumomab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether standard ...
Monoclonal antibodies, such as ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-CTLA4 monoclonal antibody).
Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...
The purpose of this study is to develop a laboratory test to determine if an individual is at risk of developing antibodies to one of these two monoclonal ...
Immunotherapy with monoclonal antibodies, such as durvalumab or cetuximab, may help the body's immune system attack the cancer, and may interfere with the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.